Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Connect 2025" conference has been added to ResearchAndMarkets.com's offering. The Global Clinical Trials Connect 2025 will provide ...

The 2023 Fall Clinical Dermatology conference featured research on treatments for alopecia areata, acne, psoriasis, atopic dermatitis, and vitiligo. The Fall Clinical Dermatology conference presented ...

MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, will present a catalog of investigational delgocitinib cream and Adbry ® data across 10 posters at the upcoming ...

The MarketWatch News Department was not involved in the creation of this content. Dubai, United Arab Emirates--(Newsfile Corp. - October 31, 2025) - International Modern Hospital (IMH) successfully ...

The 2023 Fall Clinical Dermatology conference will take place in Las Vegas and be livestreamed from October 19 to 22; topics of interest to be covered include atopic dermatitis (AD), Janus kinase (JAK ...

A Brooklyn health bigwig is heading to Miami to chair the largest clinical conference of its kind. Dr. Patrick Borgen of Maimonides Medical Center is serving as the chair of the 40th Annual Miami ...

The event featured a sensitisation workshop on public health management of chemical emergencies, organised to share critical insights into managing and mitigating the effects of chemical disasters, ...

Content warning: This article contains references to suicide. The National Suicide Prevention Lifeline is a hotline for individuals in crisis or for those looking to help someone else. To speak with a ...

Our program provides superior clinical immunology and rheumatology training in a collaborative environment. We have specialty clinics across our medical campus, which is anchored by our 1,200 bed ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (Nasdaq: BIIB) today announced new interim Phase 2 results from NURTURE, the ongoing open-label, single-arm study evaluating the efficacy and safety of ...

Preclinical in vitro studies demonstrated >80% reduction in protease activity, including complete inhibition of TACE and collagenase — key factors in non-healing chronic wounds revyve® data featured ...